Renaissance Technologies - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 204 filers reported holding BEAM THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$5,159
-99.8%
131,900
+85.0%
0.01%
+40.0%
Q3 2022$3,397,000
-68.6%
71,300
-74.5%
0.01%
-61.5%
Q2 2022$10,835,000
+410.1%
279,900
+1596.4%
0.01%
+333.3%
Q2 2021$2,124,000
-30.4%
16,500
-56.7%
0.00%
-25.0%
Q1 2021$3,050,00038,1000.00%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
MWG Management Ltd. 2,362,635$304,095,00029.88%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO 224,391$28,881,00022.15%
HSG Holding Ltd 796,089$102,465,0007.14%
DC Investments Management, LLC 21,010$2,704,0006.36%
PATHWAY CAPITAL MANAGEMENT, LP 112,197$14,441,0005.74%
Redmile Group, LLC 2,052,506$264,178,0003.91%
Casdin Capital, LLC 818,820$105,390,0002.68%
Darwin Global Management, Ltd. 126,985$16,344,0002.64%
Evolutionary Tree Capital Management, LLC 44,032$5,667,0002.61%
HHLR ADVISORS, LTD. 1,845,753$237,567,0002.44%
View complete list of BEAM THERAPEUTICS INC shareholders